Published in Cancer Weekly, April 1st, 1996
"Etoposide advances our strategy of providing our customers with a broad range of oncology products - including tools for the diagnosis, treatment, and supportive care in cancer treatment," said Michael Kranda, Immunex.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.